Researchers published findings in the journal Immunity about the activity of a protein, SHIP, which regulates how we respond to microbial infections and inflammation-inducing agents. This research has implications for cancer control and increases our understanding of allergies and autoimmune disorders such as asthma. It could play an important role in controlling septic shock in hospital patients.